Alternatives to LARVOL CLIN

Koneksa stands out as a prominent digital biomarker firm catering to the pharmaceutical and biotechnology sectors, focusing on the creation, testing, and validation of digital biomarkers that assist clients in assessing how treatments affect patients. Established in 2013, Koneksa delivers comprehensive remote clinical trial support by integrating digital health technologies, therapeutic knowledge, and swift, user-friendly remote data gathering to enhance understanding of patient health outcomes. Their innovative and validated data algorithms are designed for immediate use in treatment development initiatives, facilitating the detection of signals more rapidly than conventional methods. The company's cloud-based Software as a Service (SaaS) platform enables real-time integration of multiple endpoints, providing instant access to data and supporting informed, cost-effective decision-making early in the trial process. Additionally, this platform’s capability to gather extensive remote data at higher frequencies presents opportunities for obtaining ecologically valid measures, which can lead to a reduction in sample size while maintaining the integrity of the research. By continuously evolving their tools and methodologies, Koneksa aims to redefine how clinical trials are conducted in the modern age.

ClinCapture's mission is to create software that saves lives. ClinCapture's technology reduces the cost of clinical trials. It streamlines data capture and protects patient privacy. Clincapture is a platform that facilitates the evaluation and development drugs, biologics and devices that have the potential to treat a wide variety of medical conditions or diseases.

ClinEdge is revolutionizing the clinical trial landscape by offering a robust array of services designed specifically for Sponsors, CROs, and Sites. By employing creative and collaborative problem-solving techniques, we address the challenges and obstacles our clients encounter. Our commitment to enhancing trial success spans every phase of each study, ensuring that Sponsors and CROs have optimal Site and Patient Access while providing Site partners with improved Trial Solutions. With more than ten years of industry experience and a profound insight into our clients' needs, ClinEdge is dedicated to transforming the way studies are conducted, paving the way for more efficient and effective clinical trials. Through innovation and dedication, we aim to set new standards in the clinical trial sector.

Mosio allows research teams to improve subject adhesion, communications, data collection, and communication on mobile's most popular channel, text messaging. Our software helps research teams communicate more efficiently with participants by delivering interactive elements to mobile phones and messaging automation. WHO CAN WE HELP? + Clinical Trial Sponsors (Pharma & Biotech) + Cancer Centers and Clinical Research Organizations + NIH-Funded Studies + Public Health Agencies + Clinical Trial Managers/Directors and Clinical Operations Managers/Directors. Clinical Project Managers. Principal Investigators. Clinical Research (Study). Coordinators. All research staff who regularly communicate with study participants. BENEFITS + Interactive medication reminders and medication compliance alerts + Automate data collection. + Increase engagement and adherence. + Get SMS appointment reminders to fix your no-show problem. + Increase retention with automated check ins

Sarjen provides an integrated Clinical Trial Management System (CTMS) and Bioanalytical LIMS designed to support complete digital transformation across early-phase and late-phase clinical research. The platform brings clinical operations, site management, subject tracking, financial oversight, and laboratory sample lifecycle management into one unified ecosystem, giving sponsors, CROs, and research teams full visibility and control over their studies. With a user-friendly interface and configurable workflows, it simplifies complex processes while maintaining strict regulatory compliance and data integrity. Built as an AI-enabled solution, the software leverages advanced analytics and machine learning to improve operational efficiency and decision-making. Intelligent dashboards deliver real-time insights, predictive enrollment forecasting helps optimize recruitment strategies, and automated risk detection highlights potential delays or data inconsistencies before they impact study timelines. AI-driven query management and anomaly detection in bioanalytical data reduce manual effort and enhance accuracy across trial and laboratory operations. By combining automation, centralized data management, and smart reporting, the platform accelerates study startup, improves collaboration between clinical and lab teams, and ensures audit readiness at every stage. Through innovation, AI, and transformation-focused design, it empowers organizations to conduct faster, smarter, and more reliable clinical research while confidently navigating the evolving demands of global trials.

Suvoda is a worldwide leader in clinical trial technology, focusing on intricate, life-preserving studies in fields like oncology, central nervous system conditions, and rare diseases. Established in 2013, the company provides a comprehensive platform featuring Interactive Response Technology (IRT), electronic Consent (eConsent), electronic Clinical Outcome Assessments (eCOA), and ePatient solutions, all aimed at streamlining essential patient interactions. Their innovative software design guarantees a fluid user experience, enabling accurate randomization, efficient drug supply management, and immediate data collection. With a strong commitment to improving patient understanding and alleviating the demands on trial sites, Suvoda's offerings are designed to evolve alongside the increasing complexities of clinical trials. Based near Philadelphia, with additional offices across Europe and Asia, Suvoda has successfully supported over 1,500 trials in more than 85 countries, showcasing their global reach and expertise in the field. Their dedication to innovation and excellence positions them as a vital partner in the advancement of clinical research.

ClinAccess™ 5.1 represents the evolution of our premier Clinical Data Management System, built entirely on the robust SAS® 9 platform. This innovative system paves the way for streamlined clinical data management, efficient clinical trial analysis, and seamless preparation of electronic submissions. By integrating data entry directly into SAS® data sets, it significantly boosts your team’s efficiency by removing the cumbersome process of transferring data from Oracle/SQL to SAS. ClinAccess™ is specifically tailored for user-friendly study definition, data entry, and management, featuring tools that track the progress and quality of ongoing clinical trials. Your data is consistently maintained in SAS® for easy access, whether for review, analysis, or submission to the FDA. The underlying database architecture is optimized to facilitate rapid statistical analysis and reporting. Consequently, users can expect reduced time and effort in data analysis, ultimately leading to a faster time to market. Additionally, ClinAccess™ stands out for its reliability, comprehensive auditing capabilities, and robust security measures, making it an unparalleled choice for clinical data management. With ClinAccess™, you can confidently navigate the complexities of clinical trials while ensuring data integrity and compliance.

WCG ClinSphere represents a groundbreaking method for conducting comprehensive clinical trials. By harnessing artificial intelligence, this platform seamlessly links sites, sponsors, CROs, and participants within a single cloud-based environment. It provides a centralized hub to effectively oversee your trial from inception to completion. The architecture of WCG ClinSphere is founded on four principles of efficiency that enhance its functionality. Our extensive clinical dataset fuels a federated AI learning model, facilitating intelligent automation throughout the clinical trial process. Users can access real-time reports and insights, ensuring they remain well-informed to make prompt decisions. Tasks are simplified, and accuracy is improved through intuitive workflows that provide guidance at every stage. The platform optimizes logistics, operations, and processes during the clinical research experience, ultimately leading to faster and more effective outcomes. With the integration of vast data resources and advanced analytics, WCG ClinSphere fosters the essential connections needed for accelerated clinical research advancements. The collaborative nature of the platform also encourages innovation and continuous improvement in trial management.

At ePharmaSolutions, we are pioneering innovative approaches. While we don't classify ourselves as a high-tech firm, our foundation is built on ideas that are deeply rooted in technology yet not confined by it. We enhance the drug development landscape by offering solutions that streamline the processes of identifying, activating, training, and managing clinical trial sites. By viewing traditional challenges through a new lens, we provide technology-driven solutions designed to simplify the complexities of clinical trial management. ePharmaSolutions (ePS) stands out as a premier provider of e-clinical solutions that transform the methods of selecting, training, activating, and overseeing clinical trial sites. By infusing fresh perspectives into longstanding issues, we create innovative, technology-facilitated solutions that enable sponsors, contract research organizations, and investigator sites to effectively navigate and simplify the intricacies of clinical trial management. Our commitment to redefining these processes ensures that we remain at the forefront of the industry, continually adapting to meet evolving needs.

Replior is a pioneering company specializing in software solutions for clinical trials, featuring an integrated platform that encompasses EDC, eConsent, ePRO, and Virtual Visits to enhance trial execution. Our comprehensive system, known as Trial Online, facilitates the seamless collection and management of data from investigators, participants, and wearable devices in an efficient manner. It is designed to accommodate decentralized clinical trials (DCT), allowing for flexibility with site visits, remote interactions, or a combination of both. Our journey commenced two decades ago when we were approached to create an online CRF service for a major pharmaceutical firm, marking our transition from an IT operations provider to a dedicated software developer for clinical data collection. Over the years, we have expanded our offerings to include a complete suite of data collection services, while our IT operations are expertly managed by our highly qualified sister company, Complior. As we continue to innovate, our commitment to enhancing clinical trial processes remains at the forefront of our mission.

BSI CTMS impresses with its innovative interface and intelligent visualization of data. Our clinical trial management software is more than just an attractive interface. It includes functions that assist pharma, biotech, and diagnostics sponsors as well as CROs and academics (SMOs) in their daily lives for managing clinical trials in a targeted manner. BSI CTMS continues to be developed based on market needs and in close collaboration. BSI CTMS is unique because it offers CTMS, eTMF and Study Startup functionality in one integrated platform. Excel and other standalone solutions are overrated.

Data MATRIX offers a comprehensive SaaS solution specifically designed for clinical trials. Since its inception in 2009, the Data MATRIX team has specialized in the processing and analysis of clinical data, creating documents that comply with the standards set by the Russian Ministry of Health, FDA, and EMA. Our software streamlines clinical trial processes, allowing users to efficiently manage and track progress online. Before launching a project, we meticulously adjust and validate our software to ensure that every aspect is considered for optimal performance. With a proven track record of completing 180 projects for pharmaceutical companies, biotech firms, and CROs, our solutions have led 6 out of the top 10 Big Pharma companies to achieve a 15% reduction in R&D expenses. Our dedicated team members take pride in their involvement with professional organizations that connect clinical data professionals such as CDISC, ACDM, SCDM, biostatisticians like ISBC, and medical writers associated with EMWA and AMWA. By continually enhancing our offerings, we remain committed to driving innovation in the clinical research landscape.

Sano Genetics delivers a comprehensive 360° platform designed for precision medicine and clinical trial research, integrating various aspects such as patient recruitment, genetic testing, informed consent, and ongoing engagement to significantly enhance and streamline study processes. The platform accommodates custom protocol creation and the preparation of ethical submission documents, alongside digital prescreening and consent procedures, as well as recruitment assistance through online marketing efforts, partnerships, and advocacy groups, which allows sponsors and contract research organizations to connect with specific patient populations or those often overlooked in various regions. Additionally, Sano provides convenient, non-invasive saliva-based DNA testing kits that serve as a budget-friendly option compared to traditional clinic blood draws, along with logistical support for sample collection and processing. Their services include dependable genetic and biomarker analysis conducted by accredited laboratories, bioinformatics services, and the return of results, complemented by genetic counseling when necessary, ensuring a holistic approach to patient care and study accuracy. By leveraging technology and community engagement, Sano Genetics is poised to transform the landscape of clinical trials and personalized medicine.

Judi is an innovative cloud-based platform designed for clinical trial collaboration, aimed at enhancing, securing, and streamlining intricate workflows among sponsors, CROs, trial sites, and various partners. This platform encompasses a comprehensive array of trial functions, including endpoint and event adjudication, central eligibility assessments, data safety monitoring, remote oversight, medical imaging, site/user qualification, and personalized workflows through Judi Flex. By replacing outdated manual processes, spreadsheets, unmonitored emails, and isolated file-sharing methods, Judi creates a cohesive and compliant workspace where every document, communication, image, query, and decision flows through secure and traceable channels. Among its robust features are role-based access controls, audit trails, real-time messaging, efficient query management, customizable dashboards, worklists, flexible document submission and review processes, eCRFs with edit checks, and advanced reporting tools, which collectively enhance the efficiency and accuracy of trial data collection, review, and reporting. Furthermore, this platform’s comprehensive approach ensures that all stakeholders can collaborate seamlessly, leading to improved outcomes and faster trial timelines.

Deep 6 AI revolutionizes the patient enrollment process for clinical trials by changing how researchers pinpoint suitable candidates. By leveraging artificial intelligence and natural language processing, DEEP 6 AI efficiently sifts through both structured and unstructured patient information, enabling the identification of a larger pool of well-matched trial participants in mere minutes instead of the months typically required. The platform collaborates with leading health systems, pharmaceutical companies, and contract research organizations, positioning itself as an essential component of the clinical research ecosystem and significantly hastening the process for patients to access trials. In addition to expediting enrollment, Deep 6 AI’s innovative software evaluates structured data, like ICD-10 codes, alongside unstructured clinical information such as physician notes, pathology reports, and surgical documents that are often difficult to search through. This comprehensive analysis ensures that researchers can quickly find candidates who meet specific criteria, ultimately leading to faster delivery of groundbreaking treatments to those in need.

In recent years, the Life Sciences sector has incurred nearly $15 billion in fines and settlements related to compliance, underscoring the importance for firms to follow best practices in pharmaceuticals, medical devices, and biotechnology. Additionally, the way clinical trials are managed can greatly influence the timeline, scope, and financial resources allocated for the development of drugs or medical devices. Utilizing OpenText™ Clinical Trial Quality Management System (ctQMS) allows organizations to maintain compliance, lower record management expenses, and foster collaboration to implement best practices throughout the entire clinical trial lifecycle. This strategic approach not only enhances operational efficiency but also contributes to the overall success of product development initiatives.

Mahalo Health is an integrated digital health platform aimed at expediting the creation of patient-focused digital health solutions and clinical trials. By providing a variety of prebuilt modules, Mahalo facilitates the swift launch of customizable white-label applications that cater to particular therapeutic fields. The platform boasts comprehensive data capabilities, featuring a predictive health engine for forecasting diseases and diagnoses, a behavior modification engine to encourage beneficial patient behaviors, and a notification system that ensures timely communication through push notifications, SMS, or emails. Committed to maintaining high security and compliance standards, Mahalo follows regulations such as HIPAA, GCP, ISO27001, and GDPR. Its extensive range of services encompasses multiple therapeutic areas, including diabetes, cognitive health, cardiovascular issues, musculoskeletal conditions, mental health, oncology, rare diseases, and nonalcoholic steatohepatitis (NASH). Additionally, Mahalo Health empowers healthcare providers with tools to enhance patient engagement and outcomes through its innovative digital solutions.

Speeding up the creation of crucial medications and ensuring that patients worldwide can access top-notch cancer treatment and research equally. Our technology is transforming how patients access cutting-edge medicines and participate in clinical trials. FICS is a groundbreaking software solution that facilitates the gathering of regulatory-compliant data throughout patient treatment. By integrating previously isolated and non-interacting applications into a comprehensive, seamless platform, FICS is making clinical trials more efficient, quicker, and of superior quality, ultimately enhancing patient outcomes in significant ways.

Clin'form is an adaptable and powerful electronic Clinical Outcome Assessment (eCOA) platform that aims to simplify clinical trials for both patients and research sites, improve data integrity, and speed up processes for research teams. Its versatility allows it to be used across various protocols and demographics, making it suitable for any type of questionnaire—including Patient-Reported Outcomes (PRO), Observer-Reported Outcomes (ObsRO), Clinician-Reported Outcomes (ClinRO), and diaries—while catering to individuals of all ages, from children to the elderly. The platform is designed to handle diverse population sizes, effectively managing studies that involve anywhere from a small group to over 10,000 participants spread across multiple regions worldwide. Clin'form integrates smoothly with other clinical systems to provide an efficient workflow, supporting various data collection methods such as dedicated tablets or smartphones, the patient's personal device, web access on any browser, and in-person interviews. Noteworthy features include an integrated tele-visit option to accommodate unexpected changes and patient engagement tools that promote high levels of compliance. Additionally, Clin'form's user-friendly interface ensures that both researchers and participants can easily navigate the platform, making the clinical trial experience more streamlined and effective.

cubeCTMS is an all-encompassing clinical-trial management platform that facilitates complete oversight of trials, encompassing aspects such as tracking study sites and investigators, managing enrollment and visit schedules, and overseeing budget and contract workflows, as well as milestone reporting and document management. By centralizing study operations and automating essential processes, it allows sponsors, CROs, and study teams to oversee progress in real time, coordinate tasks across various studies, enhance communication with sites, and reduce risks. The platform offers integrated dashboards, notifications, and audit-ready documentation to ensure compliance with regulatory standards, including readiness for FDA 21 CFR Part 11, empowering stakeholders to oversee trial timelines, resources, and overall performance from a singular interface. Additionally, cubeCTMS seamlessly connects with other CRScube modules, such as EDC, eTMF, and pharmacy/RTSM, creating a cohesive ecosystem that minimizes redundancy, optimizes data flow, and supports flexible workflows during amendments or large-scale implementations. This integration not only streamlines processes but also enhances the overall efficiency of clinical trials, making it an invaluable tool for research teams.

Inspirata is a specialized oncology data and analytics platform built to help cancer programs improve care delivery and operational performance. It leverages AI-driven technology to automate cancer casefinding, data extraction, and reporting with high accuracy. The platform supports compliance with regulatory requirements while significantly reducing manual registry work. Inspirata transforms unstructured clinical data into actionable insights that fuel research and clinical decision-making. Real-time data access helps improve trial accrual and ensures equitable patient access to clinical studies. Patient navigation tools support coordinated care from screening to survivorship. By improving efficiency, Inspirata allows staff to focus on higher-value patient and research activities. The platform integrates seamlessly with major EHR and clinical systems. Trusted by hundreds of hospitals, Inspirata delivers measurable improvements in oncology operations. It helps cancer centers maximize impact while minimizing cost and complexity.

Dacima Clinical Suite, the most advanced web-based solution, combines electronic data capture (EDC), medical data management software (CDMS) and clinical trial management software into one platform. Dacima Clinical Suite is designed for clinical trials, epidemiological studies, web randomization, ePRO, surveys, and patient registers. Dacima Clinical Suite comprises three core modules: the Manager (Administrator), Designer Module, and the Data Entry Module.

Aiforia provides advanced deep learning and cloud-based solutions to pathologists and researchers in both preclinical and clinical laboratories, enhancing their capabilities in image analysis and workflow efficiency. By enabling scientists to discover new disease biomarkers and assisting R&D professionals in accelerating the market introduction of innovative drugs, Aiforia plays a crucial role in improving cancer diagnostic accuracy while revolutionizing healthcare from the initial discovery phase through to diagnosis. For clinical pathology laboratories seeking to boost efficiency and elevate the precision of their diagnoses, the Aiforia Clinical Suites present a comprehensive range of AI-driven diagnostic tools, intelligent visualization, quality control, and automated pre- and post-screening functionalities. We are in the process of developing specialized Suites targeting some of the most common cancers globally and have achieved CE-IVD certification for our AI solutions in lung and breast cancer, positioning us as a leader in diagnostic innovation. Our commitment to enhancing patient outcomes through technology underscores the transformative potential of our offerings in the healthcare sector.

ClinOne serves as a comprehensive platform that enhances connectivity and empowerment for participants, caregivers, and clinical trial sites by providing essential tools for trial awareness, consent management, and fostering participant engagement and retention, all supported by robust data analytics and standardized interoperability. Among its many features, Site Hub acts as a centralized resource for trial sites to access vital information, including criteria for participant inclusion and exclusion, site resources, and a streamlined systems landing page equipped with single sign-on capabilities and community engagement options. The Connect module further enriches the experience with features like Sponsor & Monitor Hub, trial awareness initiatives, a healthcare provider community, site selection processes, and data addressing diversity, equity, and inclusion. Meanwhile, the Inform module focuses on facilitating consent management and education through eConsent with eSignature options, as well as offering data insights, tele-visit functionalities, and avenues for community collaboration. Additionally, the Empower module enhances the overall trial experience with services such as transportation management, monitoring medication adherence, and providing a dedicated portal for care partners and caregivers, ensuring a holistic approach to participant support throughout the clinical trial journey.

Streamline your clinical studies with Clinvigilant, your global cost-effective eClinical tools provider for CROs, Pharma, Biotech, Nutraceuticals and Academic organizations in clinical and post-marketing stages. Most of our clients choose and stay with us for thanks to our: ♦ Fast EDC set-up (less than 4 weeks). ♦ Cost-effectiveness. ♦ 3rd party integrations (including legacy systems). Our cloud-based suite (Microsoft Azure) is HIPAA, ICH-GCP, GDPR & 21 CFR part 11 compliant and we have been audited by the FDA, EMA and MHRA. The Clinvigilant eClinical suite includes: EDC, CTMS, eCRF, eTMF, eSource, IWRS, ePRO, eConsent and eCOA. Just pick the tools that you need and we will integrate them within your existing software ecosystem. Every interaction and data exchange creates Audit Trails, which provide compliant real-time data visibility across all relevant roles. Our products are modular, highly customizable, and available on the web, iPad, and Mobile App for both Android and iOS. We also support Patient's Own Device (BYOD) and interface with Devices and Wearables. Clinvigilant💊, your one-stop🌐solutions provider for clinical trials☁️ .

Ready by ArcheMedX for Pharma and Biotech Trusts to better equip their trial team, improve decision-making, and reduce study delays By understanding which sites and teams are best equipped to conduct the study, you can avoid the most common causes of study delays. Reduce the time and cost of resolving problems, especially early in a trial. You can be confident that the sites you choose truly understand your patient eligibility requirements. You'll feel more confident that they will be better equipped to help you enroll eligible patients faster, meet enrollment targets, and avoid screen failures. You can be confident that the trial team is fully conversant with the protocol, down to the individual and study objectives. You can predict where there are risks so that you can avoid them and have fewer deviations overall.

Clinical Trial Search leverages artificial intelligence to streamline intricate trial information, thereby increasing both participant engagement and enrollment numbers. Advantages include: Improved Engagement: Providing straightforward language that helps potential participants understand the details better. Broader Accessibility: Connecting with a varied group of enthusiastic individuals looking for clinical trial options. Using Clinical Trial Search to list trials comes at no cost, and we also provide referral bonuses ranging from $300 to $5,000 depending on the complexity of the trial. Additionally, our platform ensures that trials are easily discoverable by those interested in participating, enhancing overall recruitment efforts.

Altis Labs has unveiled Nota, a groundbreaking clinical information platform designed to expedite therapeutic research and development. By harnessing the power of AI, Nota can forecast patient outcomes based on imaging data, allowing sponsors to efficiently prioritize their most promising therapies. This innovative platform empowers researchers to effectively utilize clinical trial imaging data, gain access to predictive imaging biomarkers, and enhance R&D efforts on a larger scale. With Altis’ cloud-based software, which employs advanced deep learning techniques, biopharma companies can integrate detailed outcome predictions at the image, patient, and cohort levels, ultimately refining clinical trial design and boosting confidence in anticipating clinical endpoints. The insights generated by Nota have the potential to drastically shorten development timelines, reduce drug development expenses, and increase the chances of success across various therapeutic areas, paving the way for a new era in clinical research. As the demand for efficient drug development continues to rise, Nota stands out as a vital tool for the biopharmaceutical industry.

Numerous choices in cancer treatment are fraught with uncertainty, and existing resources fail to assist a significant number of patients effectively. As a result, this situation contributes to preventable fatalities and the loss of billions in healthcare expenditures. Our team, which consists of experts from both computer science and oncology, is dedicated to addressing the critical challenges in cancer care using artificial intelligence. We are developing clinical-grade deep learning models that evaluate individual patient profiles and offer valuable guidance to oncologists during their decision-making processes. By placing oncologists at the forefront of our AI development, we ensure that the insights generated are not only interpretable but also actionable. Collaborating with leading academic medical institutions and community oncologists, we aim to tackle important clinical questions to improve patient outcomes. Ultimately, our goal is to enhance decision-making in cancer care and reduce the associated burdens on patients and healthcare systems.

Progressing artificial intelligence to remove the need for trial and error in healthcare, our digital twins facilitate swift and assured clinical trials. We focus on areas such as neuroscience, immunology, and metabolic diseases, among others. TwinRCTs expedite full enrollment by requiring fewer participants to provide equivalent statistical power compared to conventional trial methodologies. This approach significantly reduces the time needed for late-stage study enrollment. Additionally, TwinRCTs enhance the ability to detect treatment effects in early-stage studies by bolstering statistical power without necessitating an increase in participant numbers. They enable researchers to make informed decisions based on initial study outcomes and help attract more participants to trials. By utilizing smaller control groups, TwinRCTs also improve participants' odds of receiving the experimental treatment. Our commitment to positioning clinical trials with digital twins for regulatory success is unwavering. Unlearn is at the forefront of transforming the medical field through the innovative application of artificial intelligence, creating and implementing novel generative models that are trained on vast datasets derived from previous patient studies. This evolution in methodology not only streamlines research but also enhances the overall effectiveness of clinical trials.

Phoenix CTMS is a comprehensive, web-based clinical research platform that integrates Patient Recruitment System (PRS), Clinical Trial Management System (CTMS), and Clinical Data Management System (CDMS) capabilities into a single modular solution. The platform is designed to address the full spectrum of operational and regulatory demands faced by academic researchers, CROs, and hospitals running clinical trials at any phase. Phoenix CTMS provides a secure, private registry for sensitive patient data, ensuring compliance with EU-GDPR and other data privacy regulations. It supports a highly flexible electronic data capture (EDC) system with unlimited JavaScript form scripting for both server and browser, making it ideal for managing complex and large electronic case report forms (eCRFs). Users can conduct parallel trials while efficiently organizing site staff and resources through an intuitive interface. Unlike many commercial EDC packages, Phoenix CTMS is an open source project under LGPL 2.1, developed in collaboration with clinical trial sites at the Medical University of Graz. It is designed as a turnkey system that is operational out-of-the-box, eliminating the need for integrating multiple disparate tools. The platform is particularly suitable for users seeking a secure, private, and customizable clinical trial management solution.

Medilake is your premier solution for comprehensive clinical and non-clinical trial data management We are pleased to introduce Medilake, a versatile and innovative platform that excels at the seamless management of clinical trial and nonclinical trial data. Medilake is the best choice to simplify, optimize, and enhance data management processes in an era when data is the lifeblood for healthcare and research. Why choose Medilake to manage clinical and non-clinical trial data? Unified Data Hub - Streamlined collaboration - Data Integrity & Security Advanced Analytics - And Customization and Scalability

Oversee your clinical trial seamlessly through a single platform. Zapclinica offers an eClinical suite tailored to manage and execute every facet of your decentralized clinical trial—whether hybrid or entirely virtual. By automating intricate processes, it helps in spotting anomalies, optimizing resources, and enhancing decision-making alongside collaboration among sponsors, CROs, and study sites. This comprehensive solution significantly cuts down the time and expenses associated with running a successful clinical trial. With Zapclinica, you can handle all study components without the need for additional vendors or third-party services; instead, select the necessary applications within one unified environment, including EDC, ETMF, Payments, Logistics, and much more. Embrace the efficiency of a single platform to streamline your clinical research efforts.

EDGE, a cloud-based Clinical Trials Management System, has been successfully integrated into the UK's clinical research infrastructure and the devolved countries. Currently, EDGE is used in 80% of England's NHS regions, Scotland, and Northern Ireland. EDGE is the leading research management system in the UK. EDGE was launched in 2000 and adopted by the National Cancer Research Network. It has seen tremendous growth and has a growing number international subscribers from countries which include Canada, Belgium, New Zealand, South Africa and India.

Cloudbyz CTMS is a cloud-based trial management platform natively built on Salesforce Cloud. It is aimed at sponsors, clinical research organizations (CRO), and clinical sites for managing end-to-end clinical trial operations. Designed for clinical research, it expedites implementation and drives user adoption. Cloudbyz CTMS comes with an intuitive, straightforward design that allows for quick deployment. Boasting a rich set of features, Cloudbyz CTMS makes it easy for users to manage all aspects of clinical trials, including sites, enrolment, documents, events, milestones, site visit reports, finances, inventory, etc. The solution benefits are listed below- 1. Secure, reliable & scalable 2. Faster time to value 3. Monitor study progress & risks from planning to close-out 4. Seamless collaboration among sponsors, CROs & sites 5. Improved clinical team efficiency

AcceleTrial™ eliminates uncertainties in identifying and activating clinical trial sites. Our Study Start-up Management System (SSMS) relies on objective data rather than self-reported information. With AcceleTrial™, you gain access to a comprehensive database of thousands of globally ranked and indexed sites, evaluated based on their specific therapeutic expertise, clinical trial experience, and patient data. This system allows for an objective pairing of the most suitable sites worldwide with the relevant data on expertise, experience, and patient demographics for your clinical trials. You can swiftly engage the right sites to commence patient enrollment through AcceleTrial™'s automated “push and pull” functionality, available in multiple languages. The platform simplifies the process of gathering necessary documents with pre-filled templates and enables real-time tracking of activities. You can begin utilizing the system immediately, as it is a cloud-based solution that requires minimal IT infrastructure or training. Moreover, AcceleTrial™ can be seamlessly integrated with CTMS or other existing clinical trial management systems for enhanced efficiency. This ensures a streamlined approach to clinical trial management, allowing researchers to focus on their core objectives.

Leapcure stands at the forefront of patient recruitment and engagement, bridging the gap between clinical trial sponsors and suitable participants. By leveraging cutting-edge technology and innovative methodologies, we aim to boost both trial enrollment and patient results. Our platform simplifies the recruitment process, allowing for the rapid and efficient identification of qualified candidates for clinical trials. Committed to enhancing medical research, Leapcure strives to make clinical trials more inclusive and impactful. We collaborate intimately with both sponsors and participants to ensure seamless and fruitful trial experiences, which play a crucial role in the advancement of new therapies and treatments. Through our efforts, we are not only improving access to clinical trials but also fostering a more efficient pathway for medical breakthroughs.

Cytel stands out as a prominent global innovator in software for clinical trial design, biometrics, and advanced analytics, focusing on maximizing the efficiency of clinical trials while aiding pharmaceutical companies in harnessing the full scope of both clinical and real-world data. Established in 1987 by renowned statisticians Cyrus Mehta and Nitin Patel, Cytel has consistently been a leader in adaptive clinical trial technology and the field of biostatistics. Its software solutions, notably the East Horizon platform, facilitate accurate trial design and simulation, employing adaptive and Bayesian methodologies to enhance protocols and expedite the drug development process. The East Horizon platform serves as a comprehensive integration of Cytel's reliable software offerings, featuring R integration that significantly improves trial design functions. Furthermore, Cytel provides the Xact software suite, which is an all-encompassing toolkit designed for statistical analysis of small datasets, including those with sparse and missing data. By continuously innovating and expanding its product offerings, Cytel remains committed to providing cutting-edge solutions that meet the evolving needs of clinical research.

Most Easy-to-Use Clinical Trial Management System (CTMS) 𝐂𝐥𝐢𝐧𝐢𝐨𝐧 𝐂𝐓𝐌𝐒 integrates seamlessly with Clinion EDC and Clinion RTSM to provide detailed and faster access to the entire trial process to address all aspects of Clinical trial management from a single platform: investigator sites, patients enrollment, SAEs, deviations, inclusions, visit scheduling, IP management, milestones, finances, custom reports, and on-demand analytics enables you to improve quality, control risk, and reduce costs. Clinion CTMS is modular in design These modules are available: Admin Module Project Management Site Monitoring Activities Finance and Budget Management Safety Reporting Management of IP Inventory Document Management System Audit/Activity Log Comprehensive dashboards Comprehensive Reports

Ripple, a web-based software solution that allows for the management and recruitment of research participants in clinical, translational, and social science studies is an active registry. Ripple was developed by researchers to transform the participant workflow. It is an end-to–end research participant management system that speeds up the entire research process.

Enhance the efficiency of clinical trials using our state-of-the-art RTSM clinical supplies software. Enjoy a smooth supply management experience for clinical trials, featuring intelligent automation for forecasting, real-time tracking capabilities, and budget-friendly solutions. Don’t miss out—ask for a demo today and see the difference for yourself!

LifeSphere eTMF serves as the definitive source of truth for your clinical trial. Experience a flexible solution that simplifies inspections, guarantees compliance, and reduces the time and effort required by your organization. As the pioneering system designed to adhere to the TMF reference model, LifeSphere eTMF integrates clinical documentation with regulatory requirements and study protocols into a unified platform. Establish and oversee a singular source of truth for your clinical trial to enhance efficiency. With features that promote live collaboration and real-time document sharing, you can ensure the quality, timeliness, and completeness of your trial master file. Expedite TMF inspections swiftly and effectively to manage audits seamlessly. Furthermore, uphold compliance through built-in workflows and intuitive dashboards that facilitate straightforward trial reconstruction, making the process smoother for all stakeholders involved.

Enhance the efficiency of clinical trial operations by optimizing, automating, and analyzing data from all study management activities. Siebel CTMS offers a robust, scalable, and unified trial management platform designed to elevate operational productivity by standardizing workflows in clinical operations while delivering immediate data visibility. With Siebel CTMS, you can oversee and direct trial operations effectively from inception to completion, ensuring a seamless management experience. The system enhances data integrity by allowing customization of workflows to align with specific customer needs across various research studies. Furthermore, Siebel CTMS seamlessly integrates with sophisticated analytics tools that deliver prompt, data-driven insights into clinical programs, empowering you to make well-informed business choices. Accessing accurate and comprehensive clinical trial data in real-time enables swift and efficient decision-making, ultimately leading to improved outcomes in trial management. By leveraging these capabilities, organizations can significantly enhance their operational agility and responsiveness in the competitive clinical research landscape.

Enhance the quality of your evidence with superior electronic Patient-Reported Outcomes (ePRO) and electronic Clinical Reported Outcomes (eClinRO). These Electronic Clinical Outcome Assessments, known as eCOA, evaluate patients' feelings and functionality during clinical trials effectively. By collecting clinical data in an electronic format, you can ensure that the data from your patients is not only high-quality but also in compliance with regulatory standards. In essence, eCOA eliminates the challenges related to paper diaries, such as issues with readability, transcription mistakes, and discrepancies in data. Furthermore, the FDA advocates for the use of ePRO. This involves patients providing insights into their health through various questionnaires or assessments, which may include evaluations of quality of life or activity levels. Clinician-reported outcomes, on the other hand, involve health assessments made by a clinician, with examples such as physical examinations like PASI. Additionally, performance outcomes gauge a patient's ability to complete specific tasks, such as performing a timed activity, thereby offering a comprehensive view of their health status. Ultimately, the transition to eCOA and its associated methods signifies a move towards more reliable and efficient clinical trial processes.

Harnessing actionable insights from the leading AI-driven clinical analytics platform allows your teams to effectively manage risk and enhance performance throughout studies, systems, sites, and vendor relationships. The cutting-edge technology from Saama is specifically crafted to optimize workflows, automate labor-intensive tasks, and foster improved collaboration among various clinical functions such as operations, medical review, data management, biostatistics, and pharmacovigilance. Both sponsors and CROs depend on Saama's capabilities for data aggregation and AI solutions, which facilitate superior decision-making, minimize delays, and drastically reduce costs and timelines associated with drug development. By leveraging Saama's tools, you can accelerate the pace of clinical trial innovation. When your clinical data is centralized and continuously updated, it simplifies the lives of your ClinOps and medical review teams considerably. Furthermore, Data Managers, often undervalued, can shift their focus from repetitive tasks to the critical data points that truly drive project success, ensuring that their expertise is fully utilized in the process. This transformation not only enhances efficiency but also contributes to the overall quality of clinical outcomes.